Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis
J Thromb Thrombolysis
.
2021 Jul;52(1):124-129.
doi: 10.1007/s11239-021-02436-0.
Epub 2021 Apr 4.
Authors
Chia Siang Kow
1
,
Syed Shahzad Hasan
2
3
Affiliations
1
School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. chiasiang_93@hotmail.com.
2
School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.
3
School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.
PMID:
33813716
PMCID:
PMC8019524
DOI:
10.1007/s11239-021-02436-0
No abstract available
Publication types
Letter
Meta-Analysis
MeSH terms
Aspirin / therapeutic use*
COVID-19 / mortality*
COVID-19 Drug Treatment
Humans
Platelet Aggregation Inhibitors / therapeutic use*
Substances
Platelet Aggregation Inhibitors
Aspirin